# The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024, Regulation 138: Amendment to Schedule 8C

Extent: E+W+S+N.I.

In Schedule 8C (material to accompany an application under the unfettered access route)—
(a) in paragraph 1, omit “EU marketing authorisation or”;
(b) in paragraph 2, omit “EU marketing authorisation or”;
(c) in paragraph 3, omit “EU marketing authorisation or”.

---
Source: https://www.legislation.gov.uk/uksi/2024/832/regulation/138 (the official version)
Page: https://openlegislation.uk/human-medicines-amendments-relating-to-the-windsor-framework-regulations-2024/regulation-138
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.